Skip to content
Stock screener

ILMN Illumina, Inc. stock chart & analysis

Conviction 40HealthcareScan · Fri, Nov 6, 2026

Illumina, Inc. (ILMN) closed at $213.13 (+2.47%) on Nov 6, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 35, RS Rating 95, -31.1% from its 52-week high, +62.4% year to date. Sector: Healthcare · Laboratory Analytical Instruments.

ILMN$213.13+2.47%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
Loading chart…
Illumina, Inc.Laboratory Analytical Instrumentswww.illumina.com ↗
Price213.13
Change+2.47%
Gap-0.44%
Rel volume0.77×
Avg volume2.37M
Avg $ vol601.43M
SMA 20259.00
SMA 50249.14
SMA 200177.96
Price vs 50-14.49%
Price vs 200+19.72%
MA stackmixed
50/200 cross—
Supertrenddown · 263.23
RSI (14)35
MACD hist-8.47
MACD crossbear · 5d
Stoch %K / %D9 / 6
ADX (14)32
+DI / −DI17 / 33
RSI divergence—
MACD divergence—
ATR %7.83%
ADR %5.58%
52w high309.35
52w low112.65
From 52w high-31.13%
Above 52w low+89.13%
New 52w highNo
SqueezeOff
Bollinger width37.50%
%B0.03
Donchian pos9.02%
Donchian high294.21
Donchian low205.00
AVWAP (52w high)258.21
vs AVWAP high-17.49%
AVWAP (52w low)192.73
vs AVWAP low+10.54%
OBV trendFlat
Chaikin MF (20)-0.07
Today vs 20d0.77×
Avg vol (14d)2.46M
Avg vol (20d)2.37M
Avg $ vol (20d)601.43M
Market cap32.21B
RS Rating95 / 99
RS 3m (vs SPY)+15.95%
RS 6m (vs SPY)+50.46%
RS line new highNo
Trend template6/8
Technical rank64.7
1 week-9.72%
1 month-19.47%
3 months+11.09%
6 months+50.16%
1 year+74.00%
YTD+62.44%
P/E37.90
P/B10.24
P/S7.42
P/FCF34.60
EPS5.45
Div yield—
ROE27.03%
ROA12.48%
Debt/Eq0.37
Current2.63
EV/EBITDA29.80
Gross margin66.08%
Net margin19.57%
Rev growth-0.66%
EPS growth169.50%
Price target260.89
Target upside22.45%
Analyst ratingBuy
Institutional116.65%
Ent. value32.1B
Revenue1.13B
Net income220M
Gross profit830M
Free cash flow931M
IndustryLaboratory Analytical Instruments
ExchangeNasdaq
Shares out151.3M
Employees8.65K
ListedFri, Jul 28, 2000
Free float147.49M
Float %97.1%
Short interest—
Days to cover—
Short volume35.4%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$1.44 vs $1.36
Last surprise+5.9% beat
Setup gradeD
Conviction40 / 100
Pattern quality—
Tech rank64.7 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance301.78
Support228.95
Days since event—
Candle confirm—

Financials as of Sun, Sep 27, 2026 · quarterly.

ILMN technical analysis

Trend

ILMN's moving averages are mixed — no clean uptrend or downtrend. It closed 14.5% below the 50-day ($249.14) and 19.7% above the 200-day ($177.96). ADX(14) at 32 points to a strong, established trend. It meets 6 of 8 trend-template criteria.

Momentum

RSI(14) is 35, in the bearish half of its range. MACD crossed below its signal line 5 sessions ago. Its RS Rating of 95 puts its weighted 12-month performance ahead of about 95% of the US market.

Volume and volatility

Volume on the latest session ran 0.8× its 20-day average. It trades about $601.4M a day on average. ATR(14) is $16.68, 7.8% of price — its typical daily range. Chaikin Money Flow (-0.07) shows distribution.

Key levels

The chart pattern's support is $228.95 and its resistance $301.78. The 52-week range is $112.65 to $309.35; price is 31.1% below the high and 89.1% above the low. The VWAP anchored at the 52-week high is $258.21, above price.

Performance

ILMN returned -9.7% (1 week), -19.5% (1 month), +11.1% (3 months), +50.2% (6 months), +74.0% (1 year), +62.4% (year to date).

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Laboratory Analytical Instruments · Listed 2000 · 8,650 employees

Congress activity

Disclosed STOCK Act trades in ILMN · 8 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-02-10
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · MI · traded 2025-10-30
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · MI · traded 2025-10-31
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-09
Buy$1K–$15K
Thomas H. Kean
Thomas H. Kean
house · R · NJ · traded 2025-04-01
Buy$1K–$15K
Thomas H. Kean
Thomas H. Kean
house · R · NJ · traded 2025-04-01
Buy$1K–$15K
Michael C. Burgess
Michael C. Burgess
house · TX · traded 2024-09-03
Sell≥ $15K
Michael C. Burgess
Michael C. Burgess
house · TX · traded 2024-08-30
Sell≥ $15K

Insider activity

SEC Form 4 transactions in ILMN · open-market 10 sells

InsiderSideShares
Meister Keith A.
Director · Common Stock · 2026-11-04
Sell10.91K
Meister Keith A.
Director · Common Stock · 2026-11-04
Sell29K
Meister Keith A.
Director · Common Stock · 2026-11-04
Sell1.03K
Meister Keith A.
Director · Common Stock · 2026-11-04
Sell5K
Meister Keith A.
Director · Common Stock · 2026-11-04
Sell1.62K
Meister Keith A.
Director · Common Stock · 2026-11-04
Sell520
Meister Keith A.
Director · Common Stock · 2026-11-04
Sell1.92K
Meister Keith A.
Director · Common Stock · 2026-11-03
Sell16.88K
Meister Keith A.
Director · Common Stock · 2026-11-03
Sell52.45K
Meister Keith A.
Director · Common Stock · 2026-11-03
Sell106.93K

SEC filings

EDGAR filings in ILMN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.